What Should Be the Focus of Pharmacovigilance in the Pacific Island Countries?
摘要
Of the 14 Pacific Island Countries (PICs), only four have a population greater than 300,000, while the mean of the other 10 PICs is approximately 67,700 persons. Most of these countries cannot be expected to meet the conjoint Minimum Requirements of the Global Fund and the World Health Organization (WHO) for a functioning pharmacovigilance (PV) system. We argue that an innovative approach is required to move PV forward in such countries. Though the long-term aim is to build adequate national PV capacity, we propose an approach in which resources are focused initially towards ensuring a functioning system for the reporting of ‘problems with medicines’. The limited health system resources in these countries require that PV will be supported by some of the organizations that also provide funding aid for the supply of medicines.